Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- Unsettling Found Footage Web Series Is Equal Parts Survival Horror And Lifestyle Blog
- Three West Nile virus cases confirmed in Montrose County
- What Happens When AI Adapts to Us
- Australian Army fields AS9 Huntsman in exercise for first time
- Trump’s nutrition advisor says kids should eat food fresh from the ground
- Dartmouth Health researchers identify additional risk for those with tick
- Are Media appoints Nicole Waudby general manager, homes and lifestyle
- Public Health Issues Extreme Heat Warning
Browsing: Wellness Tips
Semaglutide in tablet form: the first oral weight-management medicine gets the green light in Europe
An average weight loss of 17%, achieved by taking one tablet in the morning every day: this is the data that convinced the European Commission to authorise the marketing of semaglutide 25 mg tablets (Novo Nordisk)
Obesity has kept more than 600,000 working-age Britons out of the labour market, according to new research from the University of York presented at the International Congress on Obesity in Mexico City, which runs from July 15-17, 2026
MEP Carlo Ciccioli, in coordination with Carlo Fidanza, Head of the Fratelli d’Italia delegation (Prime Minister Giorgia Meloni’s party within the ECR Group) in the European Parliament, and fellow members of the Parliament’s Public Health Committee, MEP Ruggero Razza and MEP Michele Picaro, have submitted a parliamentary question to the European Commission asking what concrete…
Image Plastic and reconstructive surgeon Ash Patel enters an operating room at Duke University Hospital. Photo by Mark Dolejs
Whoopi Goldberg turned heads on the red carpet last night as she not only made a rare appearance with her daughter, but also got to show off her latest weight loss
Weight isn’t the only thing people can lose while taking a GLP-1 medication like semaglutide (Wegovy and Ozempic) or tirzepatide (Zepbound and Mounjaro). Some might also experience a profound loss of joy, doctors are warning
Novo Nordisk NVO received a boost after the European Commission (EC) approved once-daily oral version of Wegovy (semaglutide 25 mg) for the treatment of adults with obesity, with at least one weight-related comorbidity, alongside a reduced-calorie diet and increased physical activity
This is a summary of a story written by Shantell Kirkendoll on Duke University School of Medicine
An empty hairdressing salon will not be transformed into a fried chcken takeaway after councillors rejected the plans despite officers recommending approval. The application, submitted by Ernest Thananjcheliyan, sought permission to change the use of the former Helen’s hairdressers at 45 Trellewelyn Road into a hot food takeaway selling fried chicken, fries, rice, and salads
Major internet corporations are increasingly favoring the “weight management” scenario when developing medical AI applications

